Andres Liivak

Partner Norton Rose Fulbright US LLP at Norton Rose Fulbright

Andres Liivak

Andres Liivak

Partner Norton Rose Fulbright US LLP at Norton Rose Fulbright

Biography

Andres Liivak is a partner in the firm's life sciences and healthcare practice in the New York office of the firm. Andres's practice focuses on health technology transactions, advising global pharmaceutical companies as well as biotechnology, medical device and other health technology concerns worldwide.

Andres designs, structures and negotiates complex collaborations, licensing, commercial arrangements and M&A transactions. Andres helps put in place arrangements for hybrid royalty profit/cost-sharing, product risk and opportunity sharing, varying allocations across multiple territories, conditional option rights and acquisition options, each of which are becoming increasingly prevalent. Andres also counsels clients on contentious transactional matters, including complex settlements of commercial and intellectual property disputes involving health technology.

Andres draws on his experience with pharmaceutical, biotech and medical device operations to work on emerging advanced health technologies. He works on health monitoring diagnostic wearables and related health data driven innovation. His multiple projects on advanced therapeutic treatment processes have given him unique experience with the apheresis related technologies used in many emerging immunotherapies and a working knowledge for the special technical, regulatory and commercialization challenges that are present.

Working within Norton Rose Fulbright's global legal practice, the firm's compelling platform helps Andres provide his clients with an integrated solution to the ever changing set of disruptive challenges to their business objectives. In particular, the combination of privacy, healthcare regulatory, competition and IP advice – globally – is increasingly important to successfully undertaking such health technology deals. Norton Rose Fulbright provides that solution.

Known for his collaborative approach and commitment to client service, Andres facilitates and enables deals by listening and appreciating the context to develop creative, effective solutions while driving deals to completion efficiently.

Andres is recognized by Legal 500 US for his work in life sciences and healthcare and as a "Life Science Star" in Euromoney's LMG Life Sciences Guide. He has also been recognized in Who's Who Legal's The International Who's Who of Life Sciences 2014, and he is recommended by PLC Which Lawyer as being among the leading lawyers throughout the US for Life Sciences: Commercial and Partnering.

Overview
RelSci Relationships

2367

Number of Awards

2

Relationships
RelSci Relationships are individuals Andres Liivak likely has professional access to. A relationship does not necessarily indicate a personal connection.

Former Group General Counsel at Novartis AG

Relationship likelihood: Strong

In-House Counsel at Novartis AG

Relationship likelihood: Strong

Senior Counsel-Legal Antitrust at Novartis AG

Relationship likelihood: Strong

In-House Counsel at Novartis AG

Relationship likelihood: Strong

Senior Legal Counsel, Mergers & Acquisitions at Novartis AG

Relationship likelihood: Strong

Vice President-Intellectual Property Transactions at Novartis AG

Relationship likelihood: Strong

Head, Corporate Legal Antitrust at Novartis AG

Relationship likelihood: Strong

Associate at Kaye Scholer LLP

Relationship likelihood: Strong

Associate at Kaye Scholer LLP

Relationship likelihood: Strong

Counsel at Kaye Scholer LLP

Relationship likelihood: Strong

In The News
Crain's New York Business
June 22, 2015
EXECUTIVE MOVES
Paths to Andres Liivak
Potential Connections via
Relationship Science
You
Andres Liivak
Partner Norton Rose Fulbright US LLP at Norton Rose Fulbright
Education
J.D.
Class of 1999

Since enrolling its first class in 1865, The George Washington University Law School has produced some of the finest minds across the spectrum of legal scholarship. That tradition continues today, as GW Law graduates use the knowledge and skills they gain here to influence the critical legal conversations of our times.

MA in Economics
Class of 1995

The University of Chicago's Office of Investments (COI) is responsible for managing the University's investment assets, which includes overseeing the endowment to ensure that it benefits both current and future generations of the University of Chicago. COI oversees the broad investment strategy and provides input to the development of the strategic and tactical investment policies of the University & UCMC endowments, pension plans and self-insurance trust assets. Their strategy combines qualitative and quantitative analysis, seeking to achieve superior investment performance on a risk-adjusted basis.COI's approach seeks to evaluate the investment strategy as an integrated part of the operating plans of the University rather than in isolation and focuses the the University's overall success, not investment returns. The endowment is well-diversified across a variety of asset classes, including global stocks and bonds, real estate, natural resources, private equity, absolute return strategies and protection (tail-hedging strategies). Asset class exposure is achieved primarily by selecting and engaging external managers. COI manages the global macro and the overlay portfolio to ensure that the portfolio's overall positioning is compliance with the endowment's investment guidelines.COI's strategies for investing in the public markets include: Absolute Return, Private Debt, Fixed Income and Credit. and Global Equities.COI's real assets team invests globally in real estate and natural resources using outside managers. The real estate portfolio invests globally in value-added and opportunistic strategies using both private partnerships and public vehicles. The natural resources portfolio invests globally in strategies that include, but are not limited to: oil and gas exploration & production; power generation; infrastructure; timber; mining and minerals; and agriculture.

B.A. in Economics, High Honors, Phi Beta Kappa
Class of 1993

Rutgers, The State University of New Jersey, is a leading national research university and the state’s preeminent, comprehensive public institution of higher education. Rutgers is dedicated to teaching that meets the highest standards of excellence; to conducting research that breaks new ground; and to providing services, solutions, and clinical care that help individuals and the local, national, and global communities where they live. Founded in 1766, Rutgers teaches across the full educational spectrum: preschool to precollege; undergraduate to graduate; postdoctoral fellowships to residencies; and continuing education for professional and personal advancement.

Career History
Partner Norton Rose Fulbright US LLP
2015 - Current

Norton Rose Fulbright is a global legal practice. We provide the world’s pre-eminent corporations and financial institutions with a full business law service. We have more than 3800 lawyers based in over 50 cities across Europe, the United States, Canada, Latin America, Asia, Australia, Africa, the Middle East and Central Asia. Recognized for our industry focus, we are strong across all the key industry sectors: financial institutions; energy; infrastructure, mining and commodities; transport; technology and innovation; and life sciences and healthcare. Wherever we are, we operate in accordance with our global business principles of quality, unity and integrity. We aim to provide the highest possible standard of legal service in each of our offices and to maintain that level of quality at every point of contact. Norton Rose Fulbright LLP, Norton Rose Fulbright Australia, Norton Rose Fulbright Canada LLP, Norton Rose Fulbright South Africa (incorporated as Deneys Reitz Inc) and Fulbright & Jaworski LLP, each of which is a separate legal entity, are members (‘the Norton Rose Fulbright members’) of Norton Rose Fulbright Verein, a Swiss Verein. Norton Rose Fulbright Verein helps coordinate the activities of the Norton Rose Fulbright members but does not itself provide legal services to clients.

Partner
Prior - 2015

Kaye Scholer LLP is a law firm representing public and private companies, governmental entities, financial institutions and other organizations. The firm offers litigation, corporate, real estate, bankruptcy tax, and trust & estates services. It was founded in 1917 and is headquartered in New York, NY.

Transactions
Details Hidden

GlaxoSmithKline Plc, ViiV Healthcare Ltd. purchase Bristol Myers Squibb Co. /HIV Research Business from Bristol-Myers Squibb Company

Details Hidden

GlaxoSmithKline Plc purchases Novartis AG /Human Vaccines Operations from Novartis AG

Details Hidden

Eli Lilly & Company purchases Novartis Animal Health, Inc. from Novartis AG

Awards & Honors
Admitted to the New Jersey Bar
Admitted to the New York Bar
Other Affiliations

Andres Liivak is affiliated with Norton Rose Fulbright, Kaye Scholer LLP

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Andres Liivak. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Andres Liivak's profile does not indicate a business or promotional relationship of any kind between RelSci and Andres Liivak.
  • be_ixf; php_sdk; php_sdk_1.4.15
  • https://relationshipscience.com/person/andres-liivak-25199214
  • https://relationshipscience.com/person/andres-liivak-25199214